Senior Director, Global Product Strategy (Berkeley Heights, NJ, US, NJ 07922)
Notify me about similar jobsAbout this opportunity
New Jersey, US | full time | Job ID: 11923
About the role:
Built on a strong scientific, technological, and clinical foundation, we are building a commercial organization to launch and drive revenue for our oncology portfolio. As Senior Director, you will lead strategy for our early-stage pipeline, spanning all assets from preclinical candidates through early Phase 2, so that the most promising science becomes differentiated medicines for patients.
You will bring a patient-centered, externally focused approach, partnering with oncology clinicians to understand their needs and those of their patients. You will work closely with Research and Development to shape early clinical programs that are designed for later regulatory and commercial success, and you will help the organization decide where to invest. As a senior leader within Global Product Strategy, you will have visibility at all levels of the organization.
Your contribution:
Set the global product strategy for the early portfolio, covering all assets from preclinical candidates through early Phase 2, across multiple modalities and tumor types.
Define target product profiles, indication prioritization, and differentiation strategy for each asset, grounded in unmet patient need and the evolving competitive and treatment landscape.
Partner with Research, Translational, and Clinical Development to design early clinical plans, including biomarker and patient-selection strategies, that create a clear path to proof of concept and to later-stage regulatory and commercial success.
Build and maintain go/no-go criteria, early commercial assessments, and market and forecast models to inform portfolio prioritization and investment decisions.
Gather insights from oncology clinicians, KOLs, patients, and payers early in development to test assumptions and shape clinical programs.
Monitor scientific, clinical, and competitor trends, and translate them into actionable implications for asset strategy and portfolio planning.
Support business development and partnering efforts by providing strategic and commercial assessments of internal and external opportunities.
Where BioNTech has co-development or co-commercialization rights, ensure alignment with partners on asset strategy and resources.
Prepare assets for a smooth transition into late-stage development by working with late-stage Global Product Strategy teams, Regulatory Affairs, Medical Affairs, and Market Access.
Lead, coach, and mentor team members, and build a high-performing, collaborative early-asset strategy function.
Own budget planning and tracking for the function, and manage vendor partnerships so work is delivered on plan, cost-effectively, and within budget.
A good match:
BS/BA with 10+ years in pharma or biotech and increasing levels of responsibility. Advanced degree a plus.
Oncology experience, including immunotherapy; knowledge of novel modalities such as mRNA, antibody-drug conjugates, or cell therapy is a strong plus.
Experience in early-stage asset strategy, early development, or translational strategy, with a record of helping advance assets from preclinical stage to clinical proof of concept.
Working knowledge of drug development, regulatory pathways, and the reimbursement and healthcare environment, and how they shape early program design.
Experience at both country/affiliate level and regional or global level, or equivalent breadth, preferred.
Prior product launch experience is valued, as it informs how early programs are designed.
Proven ability to influence and build alignment across R&D, commercial, and business development teams.
Strong analytical, strategic, organizational, and collaboration skills.
Your benefits and remuneration:
Expected Pay Range: $198,900/year to $318,300/year + benefits, annual bonus & equity (bonus and equity is variable and dependent on company and individual performance). Compensation for the role will depend on several factors, including responsibilities of the job, education, experience, knowledge, skills, and abilities.
BioNTech US is committed to employee wellbeing and offers best-in-class benefits & HR programs to support an inclusive & diverse workforce. Salaried/Position-Targeted Hourly Employees working 30+ hours per week are eligible for our comprehensive benefits package. Benefits include but are not limited to:
Medical, Dental and Vision Insurance
Life, AD&D, Critical Illness Insurance
Pre-tax HSA & FSA, DCRA Spending Accounts
Employee Assistance & Concierge Program (EAP) available 24/7
Parental and Childbirth Leave & Family Planning Assistance
Sitterstream: Virtual Tutoring & Childcare Membership
Paid Time Off: Vacation, Sick, Bereavement, Holidays (including Floating) & Year-End U.S. Shutdown.
401(K) Plan with Company Match
Tuition Reimbursement & Student Loan Assistance Programs
Wellbeing Incentive Platforms & Incentives
Professional Development Programs
Commuting Allowance and subsidized parking
Discounted Home, Auto & Pet Insurance
…and more! More details to be shared.
Berkeley Heights is New Jersey's growing hub within the life sciences industry and has already demonstrated the state’s commitment to innovation, collaboration, and excellence within the field. New Jersey's integrated approach to biotechnology and pharmaceuticals harmonizes academic rigor, industrial capability, and government support to create thriving conditions for a growing ecosystem. Cultivating an environment that seamlessly integrates cutting-edge research, robust manufacturing capabilities, and a dynamic business landscape, New Jersey has become a powerhouse in pharmaceuticals, biotechnology, and medical technology. As this region of New Jersey continues to develop, it stands ready to shape the future of medical science and technology, driving progress and improving health outcomes worldwide.
Apply now - We look forward to your application!
Apply for our New Jersey, US location and simply send us your documents using our online form.
By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘HireRight’. You will be informed accordingly by your BioNTech-Recruiter.
Job details
How this role compares
Computed from every other active BD&L & Strategic Planning role in our database, not just this employer's listings.
We currently track 116 comparable Senior Director BD&L & Strategic Planning roles across 56 biopharma companies.
Salary context
47 of 116 peers report a salary range (USD, annualized)
Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.
Where these roles are based
Top locations among the 116 comparable roles
+ 9 more countries
Seniority mix
116 of 116 peers have a known seniority level
Therapeutic area mix
31 of 116 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden
Similar opportunities
The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.
Notify me about similar jobs
Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.
Or follow a whole field: get every new BD&L & Strategic Planning job in the United States, and choose locations and companies.
How we calculate "similar"
No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.
Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.
0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.